Pharma and Biotech Industry Report: 2015-6
Pharma and Biotech Industry Report: A Year Retrospective on Mergers, Acquisitions and Technology advances 2015-6
A RECORD-BREAKING YEAR IN THE BIOTECH MARKET
2015-6 proved to be a busy time for the Pharma, Biotech and Medical (PBM) sectors. We cover these exciting developments in our new biotech industry report. Our free white paper has been researched by our experienced life science marketing consultants. It includes a full illustrated guide to M&A’s for 2015, and the start of 2016.
In summary, over this period between 2015-2016, almost $500 billion changed hands in a record-breaking number of global mergers and acquisitions (M&A). Drug portfolios were shuffled around, and FDA approvals also had a record-breaking year, with the most new drugs in over 60 years.
A variety of acquisitions and partnerships occurred that included emerging technologies for CRISPR genomic editing. In addition, CART-cell therapies and liquid biopsies for the treatment and monitoring of cancer respectively, gained significant momentum.